학술논문
The 2021 EULAR/American College of Rheumatology points to consider for diagnosis, management and monitoring of the interleukin-1 mediated autoinflammatory diseases: cryopyrin-associated periodic syndromes, tumour necrosis factor receptor-associated periodic syndrome, mevalonate kinase deficiency, and deficiency of the interleukin-1 receptor antagonist
Document Type
Article
Author
Romano, M.; Arici, Z.S.; Piskin, D.; Alehashemi, S.; Aletaha, D.; Barron, K.S.; Kastner, D.L.; Benseler, S.; Twilt, M.; Berard, R.; Broderick, L.; Dedeoglu, F.; Diebold, M.; Durrant, K.L.; Rivera, D.; Ferguson, P.; Foell, D.; Hausmann, J.; Jones, O.Y.; Lachmann, H.J.; Laxer, R.M.; Ruperto, N.; Simon, A.; Frenkel, J.; Hoffman, H.; De Jesus, A.A.; Kuemmerle-Deschner, J.B.; Ozen, S.; Gattorno, M.; Goldbach-Mansky, R.; Demirkaya, E.
Source
In: Annals of the Rheumatic Diseases . (Annals of the Rheumatic Diseases, 1 July 2022, 81(7):907-921)
Subject
Language
English
ISSN
14682060
00034967
00034967